Healthcare UX: Why User Experience Is a Patient Safety Imperative

A technical guide for Product Managers, CTOs, and Senior Engineers in medical and industrial technology

This article draws on Creative Navy's project work in medtech UX, spanning practice management software, surgical equipment, ventilators, blood pumps, infusion systems, and patient monitoring devices, including Class II and Class III regulated products. Our work in this sector covers clinical environments including the ICU and operating theatre, designing for surgeons, nurses, and biomedical engineers. Dennis Lenard, who leads this work at Creative Navy, is the author of User Interface Design For Medical Devices And Software, the practitioner reference on UX design for medical devices and software. Our approach integrates IEC 62366 usability engineering requirements and FDA Human Factors guidance as structural inputs to the design process, not post-hoc compliance activities.

Healthcare UX is not a cosmetic concern. Every interface decision in a clinical or embedded medical environment carries measurable risk to patients, to regulatory timelines, and to your organisation's bottom line. This article presents the evidence, the regulatory context, and the engineering realities that decision-makers in medical and industrial technology need to understand.

Key takeaways:

Healthcare user experience refers to the design of interactions between people and systems within clinical and medical technology environments. This spans electronic health records (EHR), patient-facing portals, infusion pumps, ventilators, diagnostic imaging systems, embedded GUIs in surgical and monitoring equipment, and remote health management platforms.

The defining characteristic that sets healthcare UX apart from consumer product design is consequence. A confusing checkout flow on a retail website leads to cart abandonment. A confusing medication ordering workflow on an infusion pump can lead to a fatal overdose.

Zhang and Walji's TURF framework provides a useful lens for understanding what healthcare UX actually involves. It breaks the problem into four interdependent layers:

IEC 62366-1 and FDA guidance are explicit: foreseeable use errors are hazards that must be mitigated through design controls. Training cannot substitute for safe design.

Clinicians override between 93% and 96% of system-generated warnings. This is not a clinician discipline problem. It is a UX design problem caused by insufficient prioritisation logic and inadequate contextual filtering.

Interface design that adds to cognitive load (redundant steps, poor information hierarchy, mismatched workflows) degrades performance and increases error rates under pressure.

36% of EHR-related adverse events involved usability issues. 5.44% of Class I and II medical device recalls were caused directly by user interface software errors.

Summative usability validation must involve at least 15 representative users per distinct user group. Foreseeable use errors must be identified, analysed, and mitigated through design controls before relying on training or labelling.

Many EHR systems prioritise billing and regulatory documentation over clinical decision-making. Documentation burden consumes one-third to one-half of a clinician's working day. Median SUS score across EHR systems is 45.9 (an F grade).

Between 36% and 88% of US adults have limited health literacy. Patient portals often create new barriers through confusing navigation and excessive medical terminology. Design for stress, pain, fear, and age-related cognitive factors: larger touch targets, high contrast, simplified flows.

Automation bias leads clinicians to over-trust AI recommendations. Explainable AI methods often fail to improve trust calibration under time pressure. AI shifts cognitive load rather than reducing it. Effective design must embed AI outputs into actionable workflow contexts.

Core metrics: task success rate, error rate, time on task, SUS, NASA-TLX. In-context simulations detect 2 to 3 times more use errors than lab conditions. Formative testing informs iteration; summative testing provides regulatory evidence.

Late-stage redesign costs 3 to 10x more than formative work. Early investment reduces regulatory risk, development cost, and safety events. For regulated devices, early usability generates the documentation regulators expect.

How does healthcare UX reduce medical errors?
By removing conditions that make errors predictable: reducing ambiguity, aligning workflows, improving alert quality, and lowering cognitive load.

Are medical devices regulated for usability?
Yes. FDA and EU MDR require summative human factors validation with documented evidence of use-error mitigation.

How do you conduct usability testing for medical devices?
Task analysis, formative prototype testing, summative validation with 15+ users per group in simulated clinical environments.

What is alert fatigue and how is it a UX problem?
Desensitisation from excessive low-priority alerts. Clinicians override 93 to 96% of warnings due to poor prioritisation and filtering.

When is the right time to start healthcare UX investment?
At the beginning of product development. Early work is far cheaper and generates required regulatory documentation.

If you are developing an embedded medical device or modernising a legacy healthcare interface, investing early in usability and human factors engineering reduces regulatory risk and long-term technical debt.